Healthy volunteers help test drug interaction in early-stage study
NCT ID NCT05550636
First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study looked at how taking multiple doses of an experimental drug called BI 1015550 changes the way the body processes midazolam, a sedative. Fifteen healthy men aged 18 to 55 took part. The goal was to see if BI 1015550 speeds up or slows down the breakdown of midazolam, which helps doctors understand how to use these drugs together safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.